A Phase IV, Prospective, Observational, Multicentre Study Evaluating the Effectiveness and Safety of Dysport® (abobotulinumtoxinA) in Paediatric Lower Limb Spasticity.
Phase of Trial: Phase IV
Latest Information Update: 28 Feb 2018
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Muscle spasticity
- Focus Therapeutic Use
- Sponsors Ipsen
- 17 Feb 2017 Status changed from not yet recruiting to recruiting.
- 13 Jan 2017 New trial record